"It is a tour de force and offers a new and potentially exciting opening for developments of new anti-obesity drugs -- something which is badly needed, " says Dr. George Bray, chief of the Division of Clinical Obesity and Metabolism at Pennington Biomedical Research Center at Louisiana State University.